Share Price and Basic Stock Data
Last Updated: February 9, 2026, 8:44 pm
| PEG Ratio | 15.64 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Godrej Agrovet Ltd operates within the animal and shrimp feed industry, focusing on enhancing agricultural productivity. As of the latest reporting period, the company’s stock price stood at ₹554 with a market capitalization of ₹10,662 Cr. The company’s revenue has displayed a robust growth trajectory, with sales reported at ₹9,374 Cr for FY 2023, marking an increase from ₹8,306 Cr in FY 2022. The trailing twelve months (TTM) revenue figures reflect a slight uptick to ₹9,765 Cr, indicating a resilient demand for its products. Quarterly sales figures reveal a steady increase, with ₹2,571 Cr recorded in September 2023, up from ₹2,445 Cr in September 2022. This consistent growth underscores Godrej Agrovet’s strategic positioning and operational capabilities within a competitive market landscape.
Profitability and Efficiency Metrics
Godrej Agrovet’s profitability metrics exhibit a mixed performance, with a reported net profit of ₹409 Cr for FY 2025, slightly lower than ₹419 Cr in FY 2022. The operating profit margin (OPM) stood at 9.16% for FY 2025, an improvement from 7.76% in FY 2024, reflecting enhanced operational efficiency. The return on equity (ROE) was reported at 17.7%, while the return on capital employed (ROCE) was at 16.6%, both of which are favorable compared to typical sector averages. However, the company has faced fluctuations in net profit over the quarters, with a notable decline to ₹23 Cr in March 2023, followed by a recovery to ₹149 Cr in June 2025. The interest coverage ratio, reported at 6.45x, suggests a comfortable position to meet interest obligations, although it indicates a potential concern given the rising interest expenses, which stood at ₹133 Cr for FY 2025.
Balance Sheet Strength and Financial Ratios
Godrej Agrovet’s balance sheet reflects a sound financial structure, with total assets amounting to ₹5,505 Cr as of March 2025. The company reported reserves of ₹2,189 Cr, which provides a cushion for future investments and operational stability. Borrowings stood at ₹1,396 Cr, resulting in a debt-to-equity ratio of 0.53, indicating a moderate use of leverage. The current ratio was reported at 0.99, suggesting that the company is nearly at par in meeting its short-term liabilities. Additionally, the book value per share was ₹123.83, while the price-to-book value ratio of 6.09x indicates a premium valuation compared to sector peers. The inventory turnover ratio improved to 6.75x, reflecting efficient inventory management, although the cash conversion cycle of 42 days suggests room for improvement in working capital management.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Godrej Agrovet indicates a strong promoter holding at 67.54%, which is a positive signal for investor confidence, reflecting stability and commitment from the founding family. The presence of foreign institutional investors (FIIs) at 7.21% and domestic institutional investors (DIIs) at 5.18% showcases a balanced investment mix, although it has seen a slight decline from previous periods. The public holding has increased to 20.08%, indicating growing retail interest in the company. The total number of shareholders stood at 1,13,067, suggesting a healthy distribution of ownership. This diverse shareholding structure can enhance liquidity and foster greater market participation, although the reduction in FII and DII holdings may warrant attention as it could reflect changing investor sentiments.
Outlook, Risks, and Final Insight
Looking ahead, Godrej Agrovet is poised for continued growth, driven by its established market presence and a focus on innovation in the animal feed sector. However, the company faces risks, including rising raw material costs and potential fluctuations in demand due to changing consumer preferences. Additionally, the increasing interest expenses could pressure profitability if not managed effectively. The company’s ability to maintain margins in a competitive environment will be crucial. Should it successfully navigate these risks while leveraging its strong brand and operational efficiencies, Godrej Agrovet could further solidify its market position. Conversely, failure to address these challenges may impact its financial performance and shareholder returns. The overall outlook remains cautiously optimistic, with growth potential contingent on strategic execution and market dynamics.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Narmada Agrobase Ltd | 124 Cr. | 32.6 | 33.6/14.6 | 32.4 | 15.3 | 0.00 % | 13.0 % | 11.2 % | 10.0 |
| Godrej Agrovet Ltd | 11,194 Cr. | 582 | 876/506 | 24.3 | 94.1 | 1.89 % | 16.6 % | 17.7 % | 10.0 |
| Avanti Feeds Ltd | 15,022 Cr. | 1,104 | 1,141/582 | 24.3 | 221 | 0.82 % | 24.0 % | 19.5 % | 1.00 |
| Ajooni Biotech Ltd | 87.3 Cr. | 5.07 | 7.74/3.55 | 17.8 | 5.29 | 0.00 % | 6.91 % | 5.15 % | 2.00 |
| Industry Average | 8,780.00 Cr | 430.92 | 24.70 | 83.92 | 0.68% | 15.13% | 13.39% | 5.75 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,324 | 2,095 | 2,510 | 2,571 | 2,345 | 2,134 | 2,351 | 2,449 | 2,450 | 2,134 | 2,614 | 2,567 | 2,718 |
| Expenses | 2,187 | 2,020 | 2,317 | 2,369 | 2,186 | 1,986 | 2,125 | 2,225 | 2,230 | 1,987 | 2,345 | 2,354 | 2,477 |
| Operating Profit | 136 | 75 | 193 | 201 | 159 | 148 | 226 | 223 | 220 | 147 | 270 | 213 | 242 |
| OPM % | 6% | 4% | 8% | 8% | 7% | 7% | 10% | 9% | 9% | 7% | 10% | 8% | 9% |
| Other Income | 84 | 23 | 32 | 20 | 21 | 20 | 25 | 25 | 22 | 25 | 24 | 18 | -5 |
| Interest | 25 | 27 | 29 | 28 | 25 | 25 | 30 | 40 | 34 | 29 | 35 | 40 | 35 |
| Depreciation | 47 | 48 | 53 | 53 | 53 | 56 | 55 | 58 | 57 | 56 | 58 | 57 | 56 |
| Profit before tax | 148 | 23 | 142 | 141 | 102 | 87 | 166 | 150 | 151 | 87 | 200 | 135 | 146 |
| Tax % | 23% | -4% | 25% | 26% | 19% | 25% | 21% | 36% | 27% | 24% | 26% | 38% | 25% |
| Net Profit | 115 | 23 | 107 | 104 | 83 | 65 | 132 | 96 | 110 | 66 | 149 | 84 | 110 |
| EPS in Rs | 6.06 | 1.61 | 5.48 | 5.48 | 4.78 | 2.97 | 7.03 | 5.84 | 5.80 | 3.68 | 8.35 | 4.81 | 5.97 |
Last Updated: February 5, 2026, 8:46 pm
Below is a detailed analysis of the quarterly data for Godrej Agrovet Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 2,718.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,567.00 Cr. (Sep 2025) to 2,718.00 Cr., marking an increase of 151.00 Cr..
- For Expenses, as of Dec 2025, the value is 2,477.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,354.00 Cr. (Sep 2025) to 2,477.00 Cr., marking an increase of 123.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 242.00 Cr.. The value appears strong and on an upward trend. It has increased from 213.00 Cr. (Sep 2025) to 242.00 Cr., marking an increase of 29.00 Cr..
- For OPM %, as of Dec 2025, the value is 9.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Sep 2025) to 9.00%, marking an increase of 1.00%.
- For Other Income, as of Dec 2025, the value is -5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Sep 2025) to -5.00 Cr., marking a decrease of 23.00 Cr..
- For Interest, as of Dec 2025, the value is 35.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 40.00 Cr. (Sep 2025) to 35.00 Cr., marking a decrease of 5.00 Cr..
- For Depreciation, as of Dec 2025, the value is 56.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 57.00 Cr. (Sep 2025) to 56.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 146.00 Cr.. The value appears strong and on an upward trend. It has increased from 135.00 Cr. (Sep 2025) to 146.00 Cr., marking an increase of 11.00 Cr..
- For Tax %, as of Dec 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 38.00% (Sep 2025) to 25.00%, marking a decrease of 13.00%.
- For Net Profit, as of Dec 2025, the value is 110.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Sep 2025) to 110.00 Cr., marking an increase of 26.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 5.97. The value appears strong and on an upward trend. It has increased from 4.81 (Sep 2025) to 5.97, marking an increase of 1.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:19 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,102 | 3,312 | 3,750 | 4,911 | 5,186 | 5,918 | 6,964 | 6,267 | 8,306 | 9,374 | 9,561 | 9,383 | 9,765 |
| Expenses | 2,863 | 3,043 | 3,579 | 4,471 | 4,741 | 5,462 | 6,475 | 5,703 | 7,637 | 8,851 | 8,856 | 8,562 | 8,915 |
| Operating Profit | 240 | 269 | 171 | 440 | 445 | 456 | 489 | 564 | 669 | 523 | 704 | 821 | 850 |
| OPM % | 8% | 8% | 5% | 9% | 9% | 8% | 7% | 9% | 8% | 6% | 7% | 9% | 9% |
| Other Income | 36 | 104 | 315 | 95 | 58 | 154 | 49 | 90 | 109 | 139 | 90 | 93 | 90 |
| Interest | 40 | 65 | 98 | 86 | 45 | 34 | 42 | 46 | 63 | 99 | 108 | 133 | 138 |
| Depreciation | 28 | 37 | 52 | 75 | 86 | 98 | 148 | 154 | 173 | 185 | 214 | 226 | 228 |
| Profit before tax | 207 | 271 | 336 | 375 | 372 | 477 | 349 | 453 | 542 | 378 | 473 | 554 | 573 |
| Tax % | 24% | 22% | 22% | 27% | 32% | 27% | 14% | 23% | 23% | 22% | 24% | 27% | |
| Net Profit | 157 | 210 | 261 | 273 | 251 | 349 | 301 | 348 | 419 | 295 | 359 | 403 | 409 |
| EPS in Rs | 118.36 | 22.69 | 28.19 | 13.44 | 11.94 | 17.13 | 15.94 | 16.33 | 20.96 | 15.71 | 18.71 | 22.35 | 22.64 |
| Dividend Payout % | 23% | 114% | 16% | 33% | 38% | 26% | 34% | 49% | 45% | 60% | 53% | 49% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 33.76% | 24.29% | 4.60% | -8.06% | 39.04% | -13.75% | 15.61% | 20.40% | -29.59% | 21.69% | 12.26% |
| Change in YoY Net Profit Growth (%) | 0.00% | -9.47% | -19.69% | -12.66% | 47.10% | -52.80% | 29.37% | 4.79% | -50.00% | 51.29% | -9.44% |
Godrej Agrovet Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 6% |
| 3 Years: | 4% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 7% |
| 3 Years: | 1% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 12% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 16% |
| 3 Years: | 15% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 5:00 am
Balance Sheet
Last Updated: December 10, 2025, 2:43 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 93 | 93 | 185 | 192 | 192 | 192 | 192 | 192 | 192 | 192 | 192 | 192 |
| Reserves | 505 | 548 | 690 | 824 | 1,219 | 1,457 | 1,646 | 1,859 | 2,076 | 2,145 | 2,324 | 2,189 | 1,618 |
| Borrowings | 620 | 685 | 1,372 | 664 | 410 | 398 | 651 | 1,007 | 1,599 | 1,433 | 1,416 | 1,396 | 2,159 |
| Other Liabilities | 435 | 417 | 957 | 1,535 | 1,714 | 2,183 | 2,183 | 1,721 | 1,689 | 1,673 | 1,734 | 1,729 | 2,136 |
| Total Liabilities | 1,573 | 1,742 | 3,111 | 3,208 | 3,535 | 4,230 | 4,672 | 4,779 | 5,556 | 5,444 | 5,667 | 5,505 | 6,105 |
| Fixed Assets | 594 | 693 | 1,507 | 1,473 | 1,492 | 2,051 | 2,178 | 2,298 | 2,407 | 2,568 | 2,806 | 2,912 | 2,884 |
| CWIP | 149 | 138 | 64 | 50 | 190 | 94 | 153 | 141 | 90 | 204 | 192 | 64 | 134 |
| Investments | 0 | 37 | 59 | 175 | 195 | 117 | 129 | 124 | 160 | 158 | 177 | 139 | 93 |
| Other Assets | 830 | 873 | 1,481 | 1,509 | 1,657 | 1,969 | 2,211 | 2,216 | 2,900 | 2,513 | 2,492 | 2,391 | 2,993 |
| Total Assets | 1,573 | 1,742 | 3,111 | 3,208 | 3,535 | 4,230 | 4,672 | 4,779 | 5,556 | 5,444 | 5,667 | 5,505 | 6,105 |
Below is a detailed analysis of the balance sheet data for Godrej Agrovet Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 192.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 192.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,618.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,189.00 Cr. (Mar 2025) to 1,618.00 Cr., marking a decrease of 571.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,159.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,396.00 Cr. (Mar 2025) to 2,159.00 Cr., marking an increase of 763.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 2,136.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,729.00 Cr. (Mar 2025) to 2,136.00 Cr., marking an increase of 407.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 6,105.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,505.00 Cr. (Mar 2025) to 6,105.00 Cr., marking an increase of 600.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,884.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,912.00 Cr. (Mar 2025) to 2,884.00 Cr., marking a decrease of 28.00 Cr..
- For CWIP, as of Sep 2025, the value is 134.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2025) to 134.00 Cr., marking an increase of 70.00 Cr..
- For Investments, as of Sep 2025, the value is 93.00 Cr.. The value appears to be declining and may need further review. It has decreased from 139.00 Cr. (Mar 2025) to 93.00 Cr., marking a decrease of 46.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,993.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,391.00 Cr. (Mar 2025) to 2,993.00 Cr., marking an increase of 602.00 Cr..
- For Total Assets, as of Sep 2025, the value is 6,105.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,505.00 Cr. (Mar 2025) to 6,105.00 Cr., marking an increase of 600.00 Cr..
However, the Borrowings (2,159.00 Cr.) are higher than the Reserves (1,618.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -380.00 | -416.00 | 170.00 | -224.00 | 35.00 | 58.00 | -162.00 | 563.00 | 668.00 | 522.00 | 703.00 | 820.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 27 | 30 | 44 | 39 | 44 | 45 | 45 | 48 | 42 | 22 | 20 | 22 |
| Inventory Days | 47 | 54 | 83 | 71 | 70 | 72 | 60 | 78 | 83 | 66 | 70 | 66 |
| Days Payable | 33 | 30 | 42 | 81 | 82 | 99 | 87 | 62 | 40 | 35 | 32 | 47 |
| Cash Conversion Cycle | 40 | 54 | 85 | 29 | 31 | 18 | 17 | 64 | 84 | 54 | 58 | 42 |
| Working Capital Days | 33 | 49 | -51 | -26 | -8 | -3 | -7 | 7 | 6 | -4 | 1 | -2 |
| ROCE % | 24% | 24% | 17% | 19% | 20% | 18% | 15% | 16% | 16% | 10% | 14% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 4,021,039 | 0.34 | 229.68 | 2,240,862 | 2025-12-08 07:42:13 | 79.44% |
| Franklin India Large & Mid Cap Fund | 934,321 | 1.45 | 53.37 | 818,264 | 2026-01-25 05:57:56 | 14.18% |
| UTI Small Cap Fund | 690,986 | 0.83 | 39.47 | N/A | N/A | N/A |
| Tata India Consumer Fund | 315,000 | 0.67 | 17.99 | N/A | N/A | N/A |
| Tata Retirement Savings Fund - Progressive Plan | 292,000 | 0.79 | 16.68 | N/A | N/A | N/A |
| Tata Retirement Savings Fund - Moderate Plan | 252,000 | 0.66 | 14.39 | N/A | N/A | N/A |
| Groww Value Fund | 7,250 | 0.61 | 0.41 | N/A | N/A | N/A |
| Tata Retirement Savings Fund - Conservative Plan | 7,000 | 0.23 | 0.4 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 22.35 | 18.71 | 15.71 | 20.96 | 16.34 |
| Diluted EPS (Rs.) | 22.34 | 18.71 | 15.71 | 20.95 | 16.33 |
| Cash EPS (Rs.) | 29.95 | 27.14 | 23.36 | 28.23 | 23.50 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 123.83 | 151.97 | 142.78 | 139.96 | 128.15 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 123.83 | 151.97 | 142.78 | 139.96 | 128.15 |
| Revenue From Operations / Share (Rs.) | 488.00 | 497.40 | 487.81 | 432.36 | 326.27 |
| PBDIT / Share (Rs.) | 44.71 | 38.64 | 32.80 | 38.78 | 31.41 |
| PBIT / Share (Rs.) | 32.95 | 27.49 | 23.15 | 29.76 | 23.39 |
| PBT / Share (Rs.) | 26.02 | 21.88 | 17.99 | 25.58 | 20.97 |
| Net Profit / Share (Rs.) | 18.19 | 15.99 | 13.71 | 19.20 | 15.48 |
| NP After MI And SOA / Share (Rs.) | 22.35 | 18.71 | 15.71 | 20.96 | 16.33 |
| PBDIT Margin (%) | 9.16 | 7.76 | 6.72 | 8.97 | 9.62 |
| PBIT Margin (%) | 6.75 | 5.52 | 4.74 | 6.88 | 7.17 |
| PBT Margin (%) | 5.33 | 4.39 | 3.68 | 5.91 | 6.42 |
| Net Profit Margin (%) | 3.72 | 3.21 | 2.80 | 4.44 | 4.74 |
| NP After MI And SOA Margin (%) | 4.57 | 3.76 | 3.22 | 4.84 | 5.00 |
| Return on Networth / Equity (%) | 18.04 | 14.29 | 12.91 | 17.74 | 15.29 |
| Return on Capital Employeed (%) | 19.12 | 15.05 | 14.31 | 19.39 | 15.89 |
| Return On Assets (%) | 7.79 | 6.30 | 5.50 | 7.20 | 6.53 |
| Long Term Debt / Equity (X) | 0.19 | 0.11 | 0.02 | 0.02 | 0.07 |
| Total Debt / Equity (X) | 0.53 | 0.51 | 0.56 | 0.69 | 0.45 |
| Asset Turnover Ratio (%) | 1.67 | 1.71 | 1.69 | 1.60 | 1.11 |
| Current Ratio (X) | 0.99 | 1.04 | 0.96 | 1.06 | 1.08 |
| Quick Ratio (X) | 0.39 | 0.37 | 0.36 | 0.48 | 0.55 |
| Inventory Turnover Ratio (X) | 6.75 | 4.90 | 4.91 | 4.87 | 3.88 |
| Dividend Payout Ratio (NP) (%) | 44.74 | 50.76 | 60.46 | 38.17 | 33.67 |
| Dividend Payout Ratio (CP) (%) | 29.31 | 31.81 | 37.45 | 26.68 | 22.58 |
| Earning Retention Ratio (%) | 55.26 | 49.24 | 39.54 | 61.83 | 66.33 |
| Cash Earning Retention Ratio (%) | 70.69 | 68.19 | 62.55 | 73.32 | 77.42 |
| Interest Coverage Ratio (X) | 6.45 | 6.89 | 6.36 | 11.81 | 12.98 |
| Interest Coverage Ratio (Post Tax) (X) | 3.62 | 3.85 | 3.66 | 7.12 | 7.40 |
| Enterprise Value (Cr.) | 15963.39 | 11014.00 | 9629.43 | 10447.66 | 11375.23 |
| EV / Net Operating Revenue (X) | 1.70 | 1.15 | 1.03 | 1.26 | 1.82 |
| EV / EBITDA (X) | 18.57 | 14.83 | 15.28 | 14.02 | 18.85 |
| MarketCap / Net Operating Revenue (X) | 1.55 | 0.97 | 0.84 | 1.02 | 1.61 |
| Retention Ratios (%) | 55.25 | 49.23 | 39.53 | 61.82 | 66.32 |
| Price / BV (X) | 6.09 | 3.72 | 3.39 | 3.75 | 4.91 |
| Price / Net Operating Revenue (X) | 1.55 | 0.97 | 0.84 | 1.02 | 1.61 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.04 | 0.03 |
After reviewing the key financial ratios for Godrej Agrovet Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 22.35. This value is within the healthy range. It has increased from 18.71 (Mar 24) to 22.35, marking an increase of 3.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 22.34. This value is within the healthy range. It has increased from 18.71 (Mar 24) to 22.34, marking an increase of 3.63.
- For Cash EPS (Rs.), as of Mar 25, the value is 29.95. This value is within the healthy range. It has increased from 27.14 (Mar 24) to 29.95, marking an increase of 2.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 123.83. It has decreased from 151.97 (Mar 24) to 123.83, marking a decrease of 28.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 123.83. It has decreased from 151.97 (Mar 24) to 123.83, marking a decrease of 28.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 488.00. It has decreased from 497.40 (Mar 24) to 488.00, marking a decrease of 9.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 44.71. This value is within the healthy range. It has increased from 38.64 (Mar 24) to 44.71, marking an increase of 6.07.
- For PBIT / Share (Rs.), as of Mar 25, the value is 32.95. This value is within the healthy range. It has increased from 27.49 (Mar 24) to 32.95, marking an increase of 5.46.
- For PBT / Share (Rs.), as of Mar 25, the value is 26.02. This value is within the healthy range. It has increased from 21.88 (Mar 24) to 26.02, marking an increase of 4.14.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 18.19. This value is within the healthy range. It has increased from 15.99 (Mar 24) to 18.19, marking an increase of 2.20.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 22.35. This value is within the healthy range. It has increased from 18.71 (Mar 24) to 22.35, marking an increase of 3.64.
- For PBDIT Margin (%), as of Mar 25, the value is 9.16. This value is below the healthy minimum of 10. It has increased from 7.76 (Mar 24) to 9.16, marking an increase of 1.40.
- For PBIT Margin (%), as of Mar 25, the value is 6.75. This value is below the healthy minimum of 10. It has increased from 5.52 (Mar 24) to 6.75, marking an increase of 1.23.
- For PBT Margin (%), as of Mar 25, the value is 5.33. This value is below the healthy minimum of 10. It has increased from 4.39 (Mar 24) to 5.33, marking an increase of 0.94.
- For Net Profit Margin (%), as of Mar 25, the value is 3.72. This value is below the healthy minimum of 5. It has increased from 3.21 (Mar 24) to 3.72, marking an increase of 0.51.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.57. This value is below the healthy minimum of 8. It has increased from 3.76 (Mar 24) to 4.57, marking an increase of 0.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.04. This value is within the healthy range. It has increased from 14.29 (Mar 24) to 18.04, marking an increase of 3.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.12. This value is within the healthy range. It has increased from 15.05 (Mar 24) to 19.12, marking an increase of 4.07.
- For Return On Assets (%), as of Mar 25, the value is 7.79. This value is within the healthy range. It has increased from 6.30 (Mar 24) to 7.79, marking an increase of 1.49.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has increased from 0.11 (Mar 24) to 0.19, marking an increase of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.53. This value is within the healthy range. It has increased from 0.51 (Mar 24) to 0.53, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.67. It has decreased from 1.71 (Mar 24) to 1.67, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1.5. It has decreased from 1.04 (Mar 24) to 0.99, marking a decrease of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.39, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.75. This value is within the healthy range. It has increased from 4.90 (Mar 24) to 6.75, marking an increase of 1.85.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 44.74. This value is within the healthy range. It has decreased from 50.76 (Mar 24) to 44.74, marking a decrease of 6.02.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 29.31. This value is within the healthy range. It has decreased from 31.81 (Mar 24) to 29.31, marking a decrease of 2.50.
- For Earning Retention Ratio (%), as of Mar 25, the value is 55.26. This value is within the healthy range. It has increased from 49.24 (Mar 24) to 55.26, marking an increase of 6.02.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 70.69. This value exceeds the healthy maximum of 70. It has increased from 68.19 (Mar 24) to 70.69, marking an increase of 2.50.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.45. This value is within the healthy range. It has decreased from 6.89 (Mar 24) to 6.45, marking a decrease of 0.44.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.62. This value is within the healthy range. It has decreased from 3.85 (Mar 24) to 3.62, marking a decrease of 0.23.
- For Enterprise Value (Cr.), as of Mar 25, the value is 15,963.39. It has increased from 11,014.00 (Mar 24) to 15,963.39, marking an increase of 4,949.39.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.70, marking an increase of 0.55.
- For EV / EBITDA (X), as of Mar 25, the value is 18.57. This value exceeds the healthy maximum of 15. It has increased from 14.83 (Mar 24) to 18.57, marking an increase of 3.74.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.55, marking an increase of 0.58.
- For Retention Ratios (%), as of Mar 25, the value is 55.25. This value is within the healthy range. It has increased from 49.23 (Mar 24) to 55.25, marking an increase of 6.02.
- For Price / BV (X), as of Mar 25, the value is 6.09. This value exceeds the healthy maximum of 3. It has increased from 3.72 (Mar 24) to 6.09, marking an increase of 2.37.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.55, marking an increase of 0.58.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Godrej Agrovet Ltd:
- Net Profit Margin: 3.72%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.12% (Industry Average ROCE: 15.13%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.04% (Industry Average ROE: 13.39%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.39
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.3 (Industry average Stock P/E: 24.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.53
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.72%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Animal/Shrimp Feed | Godrej One, 3rd Floor, Mumbai Maharashtra 400079 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nadir B Godrej | Chairman & Non-Exe.Director |
| Mr. Balram S Yadav | Managing Director |
| Mr. Burjis Godrej | Executive Director |
| Ms. Tanya A Dubash | Non Executive Director |
| Ms. Nisaba Godrej | Non Executive Director |
| Mr. Pirojsha A Godrej | Non Executive Director |
| Mr. Kannan Sitaram | Independent Director |
| Ms. Roopa Purushothaman | Independent Director |
| Ms. Aditi Kothari Desai | Independent Director |
| Dr. Ritu Anand | Independent Director |
| Mr. Natarajan Srinivasan | Independent Director |
| Ms. Ritu Verma | Independent Director |
| Dr. Ashok Gulati | Independent Director |
FAQ
What is the intrinsic value of Godrej Agrovet Ltd?
Godrej Agrovet Ltd's intrinsic value (as of 10 February 2026) is ₹335.04 which is 42.43% lower the current market price of ₹582.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹11,194 Cr. market cap, FY2025-2026 high/low of ₹876/506, reserves of ₹1,618 Cr, and liabilities of ₹6,105 Cr.
What is the Market Cap of Godrej Agrovet Ltd?
The Market Cap of Godrej Agrovet Ltd is 11,194 Cr..
What is the current Stock Price of Godrej Agrovet Ltd as on 10 February 2026?
The current stock price of Godrej Agrovet Ltd as on 10 February 2026 is ₹582.
What is the High / Low of Godrej Agrovet Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Godrej Agrovet Ltd stocks is ₹876/506.
What is the Stock P/E of Godrej Agrovet Ltd?
The Stock P/E of Godrej Agrovet Ltd is 24.3.
What is the Book Value of Godrej Agrovet Ltd?
The Book Value of Godrej Agrovet Ltd is 94.1.
What is the Dividend Yield of Godrej Agrovet Ltd?
The Dividend Yield of Godrej Agrovet Ltd is 1.89 %.
What is the ROCE of Godrej Agrovet Ltd?
The ROCE of Godrej Agrovet Ltd is 16.6 %.
What is the ROE of Godrej Agrovet Ltd?
The ROE of Godrej Agrovet Ltd is 17.7 %.
What is the Face Value of Godrej Agrovet Ltd?
The Face Value of Godrej Agrovet Ltd is 10.0.